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Although the true morbidity and mortality rates of
untreated acute deep venous thrombosis (DVT) are
unknown, late sequelae of post-thrombotic syndrome
may develop in as many as 66% of patients.1-3 The inhi-
bition of thrombus propagation, the restoration of
patency of the thrombosed veins, the prevention 
of pulmonary embolism, and the preservation of
venous valvular competence to avoid chronic venous
insufficiency are the ultimate goals of treatment.
Anticoagulation therapy, thrombolytic therapy (TL),
and surgical thrombectomy (TX) are the available
treatment methods that attempt to achieve these goals.
TX for iliofemoral DVT initially was received
with high enthusiasm since its first report in 1937 by
Läwen4-7 but was replaced by medical therapy when
the early reports failed to show lasting benefits.8-10
However, with the refinement of surgical techniques
and the construction of temporary arteriovenous fis-
tula, TX has re-emerged as a therapeutic alterna-
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Purpose: The experiments were designed to compare the effects of thrombolytic therapy
(TL) and balloon-catheter thrombectomy (TX) on valvular competence, thrombogenicity,
venous wall morphology, and function after acute deep venous thrombosis (DVT) in
canine veins. 
Methods: The femoral veins of male mongrel dogs were ligated proximally and distally for
48 hours to induce DVT. The thrombosed veins were treated with either TL (n = 5) or
TX (n = 9), or no treatment was rendered (n = 6). Sham-operated dogs were used as
controls. TL was performed with catheter-directed infusion of urokinase at 4000
U/min for 90 minutes. Three hours after the treatment, the valvular competence was
determined with duplex scanning, thrombogenicity determined with deposition of
radio-labeled platelet and fibrin, and function determined with response to contractile
and relaxing agonists in organ chambers. The structural integrity of the endothelial layer
was assessed by means of scanning electron microscopy.
Results: The removal or lysis of the thrombus was successful in all cases. The valvular
competence did not differ among the groups. The platelet deposition was the highest
after TX (P < .05), and the fibrin deposition was not significantly different among the
groups. In the organ chamber experiments, relaxations to adenosine diphosphate and
nitric oxide were reduced after TX (P < .05). The contractions to serotonin were
enhanced after TX. Scanning electron microscopy results showed a comparable (51% to
75%) endothelial loss with either treatment.
Conclusions: After experimental acute DVT, the TL and the TX at 3 hours had similar
effects on the valvular competence and the endothelial morphology. However, the TL
reduced thrombogenicity, which is consistent with the preserved endothelial responses to
platelet products. These data suggest that TL may preserve vein function after DVT and
may reduce the long-term potential for recurrent DVT and post-thrombotic syndrome.
(J Vasc Surg 1998;28:787-99.)
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tive.11-20 Consequently, the question has been raised
as to whether TL or TX should be implemented as
the first line of therapy for this potentially lethal and
morbid disease.
The vascular endothelium releases vasoactive
substances, such as nitric oxide (NO), prostacyclin,
and endothelin-1, which influence the tone, differ-
entiation, and growth of the underlying smooth
muscle.21-23 Recent experimental studies from our
laboratory confirmed that in acutely thrombosed
canine iliac arteries, TL with urokinase caused no or
minimal abnormalities in endothelial and smooth
muscle functions and arterial balloon TX significant-
ly affected the endothelium-dependent functions of
the arterial wall.24 It was postulated that the venous
endothelium will be affected by the removal of
thrombus with either TL or TX. Thus, production
of endothelium-derived factors may be altered after
the removal of the thrombus, which may in turn
affect thrombogenicity and smooth muscle function.
These phenomena may result in recurrent DVT and
valvular incompetence. The endothelium-dependent
function of the venous wall or thrombogenicity dur-
ing and after treatment of acute thrombosis is not
known.
Therefore, the present study was designed to
determine and compare the early functional and
morphologic changes in veins after the treatment of
acute experimental venous thrombosis with either
TL or TX.
MATERIALS AND METHODS 
Animal care was in compliance with the
“Principles of laboratory animal care” formulated by
the National Society for Medical Research and the
“Guide for the care and use of laboratory animals”
prepared by the National Academy of Sciences and
published by the National Institutes of Health (NIH
publication no. 86-23, revised 1985).
Acute DVT was induced in anesthetized (intra-
venous sodium pentobarbital, 30 mg/kg) adult
male mongrel dogs (weight, 21 to 26 kg) by ligating
the proximal and the distal bilateral common
femoral veins and the intervening tributaries. For
the control group, the veins were exposed but not
ligated (sham; SH) in another group of dogs.
Study groups and interventions
The thrombus formation was confirmed with
duplex scanning (Apogee 800, ATL, Ambler, Pa).
The preliminary experiments were conducted in 2
dogs (4 vessels) with DVT of 72-hours duration.
These veins did not contract at all to norepinephrine
(NE; 3 · 10-7 mol/L) in the organ chamber studies.
Therefore, all of the subsequent studies were per-
formed 48 hours after the thrombus formation, at
which time the ligatures were removed. The animals
then were randomly assigned to one of the study
groups.
No treatment (NT; n = 6). The thrombosed
veins were dissected from the adjacent tissues and
transected proximally and distally. The intraluminal
thrombus was not disturbed until after the cutting
of the specimen into rings for organ chamber
experiments. 
Thrombectomy (n = 9). The thrombus was
removed with a #4 Fogarty balloon catheter (Baxter
Healthcare, Santa Ana, Calif). The locking hub of a
Fogarty catheter was severed, and the cut end was
passed through a side branch at the level of the
popliteal fossa proximally to avoid valvular destruc-
tion during the procedure (Fig 1). The cut end was
retrieved through a proximal venotomy, and a 25-
gauge needle was connected to the end. A force
transducer was connected to the proximal portion of
the catheter. TX was effected by withdrawing the
catheter at a constant speed and by keeping the pres-
sure as close as possible to 60 mm Hg to keep the
variability in linear shear stress to a minimum.24 The
completeness of the TX was confirmed with duplex
scanning. One vein was removed from each dog 3
hours after flow was re-established. This vein was
prepared for functional and histologic studies. The
dogs then were injected with radio-labeled platelet
and fibrin. After an additional 3 hours, the remain-
ing vein was harvested for the assessment of throm-
bogenicity as described below. 
Thrombolysis (n = 5). A small tributary at the
level of the distal extent of the thrombus was cannu-
lated with a 14-gauge Teflon catheter, which then
was advanced directly into the thrombus. Urokinase
(Abbokinase, Abbot Laboratories, North Chicago,
Ill) was infused directly into the thrombus (Harvard
Apparatus, Millis, Mass) through the catheter. A
method of preparation of urokinase has been
described previously.24 The lytic agent was infused
continuously at 0.43 mL/min (4000 U/min) until
the complete lysis of the thrombus. Serial duplex
scanning was performed at 30, 60, and 90 minutes
or until the complete lysis was achieved. After com-
plete TL, the flow was re-established for 3 hours.
This vein was prepared for functional and histologic
studies. The dog then was injected with radio-
labeled platelet and fibrin. After an additional 3
hours, the remaining vein was harvested for the
assessment of thrombogenicity as described below. 
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Sham (n = 6). The control femoral veins that
were exposed but not ligated were studied 48 hours
later for thrombogenicity, function, and morphology.
Determination of valvular competence
Before the induction of DVT and immediately
after each treatment, a side branch at the level of the
popliteal fossa was cannulated with a 14-gauge
angiocatheter. With the dogs in 15-degree reverse
Trendelenburg position, an end-inspiratory pressure
of 16 mm Hg was generated with a ventilator and
held in place while assessing valvular competence.
The angiocatheter was opened to air to allow the free
flow of blood, such that the competent distal valve
would not impede the blood flow and render false-
negative (competent) results. The incompetence of
the venous valves was confirmed, with a high-defini-
tion color-flow duplex scanner by visualization of the
reversal of blood flow in the venous segments. The
result was confirmed by a strip test,25 which correlat-
ed with duplex scanning in all cases. The strip test
includes the manual occlusion of venous inflow to
the segment of the vein that contains a valve. The
blood then is stripped from the vein cephalad and
allowed to fill by retrograde flow. The filling of the
stripped segment indicates an incompetent valve.
Determination of thrombogenicity
Radio-labeled platelets (autologous platelets
labeled with 111In oxyquinoline, Amersham Corp,
Arlington Heights, Ill) and human 125I-labeled fi-
brinogen (1.9 m Ci/kg; Amersham Corp)226 were
injected into the animals 3 hours after the treatment
and circulated for an additional 3 hours. The remain-
ing vein was removed, and thrombogenicity was
determined by measuring the radioactivity of platelet
and fibrin with a 2-channel gamma counter (Packard
Instrument, Downers Grove, Ill).
Platelet26 and fibrin deposition (Appendix) were
determined with the following formulas:
Platelet deposition =
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Fig 1. Diagram shows balloon thrombectomy.
Determination of function
Three hours after the designated treatment and
before the injection of the radio-labeled platelets and
fibrinogen, 1 vein was removed, cleaned of connective
tissue, and cut into rings that were 5 mm in length.
The rings were placed in a buffered saline solution
(composition in mmol/L): NaCl 118.3, KCl 4.7,
CaCl2 2.5, MgSO4 1.2, KH2PO4 1.22, NaHCO3
25.0, glucose 11.1, and CaEDTA 0.026. Care was
taken not to render iatrogenic injury to the veins. To
study the responses of the smooth muscle indepen-
dent of the influence of endothelium, the endotheli-
um was removed mechanically from half of the rings
by gently rubbing the luminal surface with a saline
solution–wetted cotton-tipped applicator. The rings
then were mounted between a clip and a force trans-
ducer (UTC-2, Gould Instruments, Cleveland, Ohio)
for isometric force measurements in an organ bath that
was filled with 25 mL of buffered saline solution at
37°C and then were aerated with a 95% O2/5% CO2
mixture. The optimal length-tension curve was deter-
mined by the magnitude of the contraction to NE (3
· 10-7 mol/L) at increasing levels of stretch. After this
process, the maximal tension to NE (10-4 mol/L) was
measured. When the tension had returned to the rest-
ing levels, all of the rings were incubated with
indomethacin (10-5 mol/L) to inhibit the production
of prostanoids. The responses in the absence and the
presence of L-arginine analogue, NG-monomethyl-L-
arginine (L-NMMA, 10-4 mol/L), were obtained to
determine the changes in the production of NO.
The products of the aggregating platelets, adeno-
sine diphosphate (ADP) and serotonin (5-hydrox-
ytryptamine), were used to determine the responses of
the endothelium and the smooth muscle cells (SMCs).
The rings, with and without the endothelium and in
the absence and the presence of L-NMMA, were stud-
ied in parallel. To study the relaxations, the rings were
contracted with a concentration of prostaglandin F2a
(PGF2a ), which produces 50% of the maximal con-
traction to NE. Once the contractions stabilized, 
the cumulative concentration–response curves were
obtained to the following drugs in the specified order:
adenosine diphosphate (10-8 to 10-4 mol/L) followed
by calcium ionophore A23187 (10-9 to 10-6 mol/L)
in rings with endothelium or by NO (3 · 10-9 to 
10-5 mol/L) in the rings without endothelium.
Serotonin was given from the baseline tension to
quantitate the contractions.
A gas bulb that was fitted with a silicon rubber
injection septum was filled with NO from a tank
(Union Carbide, Chicago, Ill). An appropriate vol-
ume (10 to 1000 m L) was aspirated with a syringe
and injected into the other gas bulbs that were filled
with distilled water that had been gassed with heli-
um for 3 hours, which gave a stock solution of NO
of 0.01%, 0.1%, and 1%.21
The following drugs were all from Sigma Chemical
Co (St Louis, Mo): adenosine diphosphate, the calci-
um ionophore A23187, indomethacin, PGF2a , and 5-
hydoxytryptamine creatinine sulfate (serotonin). All of
the drugs were prepared daily in distilled water, kept on
ice, and added to 25-mL organ chamber baths. The
calcium ionophore was dissolved in dimethyl sulfoxide
and diluted in distilled water (final concentration, 8.2
· 10-5 mol/L). Indomethacin (10 mg) was mixed with
NaHCo3 (5 mg) and diluted in distilled water (final
concentration, 10-5 mol/L).
Histology
The anatomy of the vein wall was assessed by
means of light and scanning electron microscopy
(SEM). A 1-cm segment of the vein that contained
a valve in its mid-portion was obtained and divided
in half longitudinally. One half was stored in 4% glu-
taraldehyde (Sigma Chemicals) for SEM.
The rings with and without endothelium from the
organ chamber study were fixed in 10% formalin,
paraffin embedded, and stained with hematoxylin and
eosin for light microscopy to assess the presence or
the absence of endothelium. After glutaraldehyde fix-
ation, a separate set of veins were fixed in 1% OsO4,
embedded in epoxy resin, and stained with methyl-
ene-blue to determine the degree of SMC injury with
the following scale: 0, no or superficial smooth mus-
cle cell injury that involved only 1 layer of SMC; and
1, deep injury of the media that involved 2 or more
layers of the SMC. The presence or the absence of
smooth muscle layer injury was assessed by means of
light microscopy. 
With SEM, endothelial denudation was scored by
an observer (GM) who was blinded to the treatment
method. The vein rings were sectioned into quad-
rants, and the percentage of endothelial denudation
was assessed with the following scoring system: 1, 0
to 10%; 2, 11% to 25%; 3, 26% to 50%; 4, 51% to 75%;
and 5, 76% to 100%. The results are expressed as a
mean score ± the standard error of the mean (sem).
Calculations and statistical analysis
All data are expressed as mean ± sem. Relaxations
are expressed as a percentage of the contraction to
PGF2a , and contractions as a percentage of the max-
imal contraction to NE. The duration of reflux was
reported in seconds. Platelet deposition and fibrin
deposition are recorded as counts/cm2 and m g/cm2,
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respectively. The difference in valvular competence
and the presence or absence of smooth muscle layer
among groups were determined with c 2 test. The
differences in platelet/fibrin deposition, relaxations
or contractions, and the degree of endothelial injury
among groups were determined with 1-way analysis
of variance. Tukey test was used to identify the dif-
ferences between the groups. A Student t test for
paired responses was used to compare the pairs of
rings studied in the presence or the absence of L-
NMMA or in the presence or the absence of
endothelium. Statistical significance was accepted
when P < .05. 
RESULTS 
The results of duplex scanning confirmed DVT
in all vessels 48 hours after ligation. The treatment
of thrombus was achieved with either TX or TL,
whereas the presence of intraluminal thrombus was
confirmed in the untreated vessels at harvest.
Valvular competence
No incompetent valves were detected before DVT
formation. Valvular incompetence after the treatment
was not statistically different among the groups and
was detected in 1 of 12 SH veins (8.3%), 4 of 15 TX
veins (26.7%), and 1 of 11 TL veins (9.1%).
Thrombogenesis
The preoperative hematocrit and platelet counts
did not differ among the groups. The hematocrit
counts were 44.7%, 45.5%, and 47.7%, and the
platelet counts were 264,400/ m L, 335,000/ m L,
and 296,800/ m L in the SH, TL, and TX groups,
respectively. The rate of efficiency of labeling the
platelets with 111In was similar at 83.6%, 88.3%, and
89.4%, in the SH, TL, and TX groups, respectively. 
After treatment, all of the dogs were examined
for the presence of rethrombosis. After TX, rethrom-
bosis was observed within 3 hours after TX in 5 of
the 9 dogs that were studied. TL was achieved with-
in 90 minutes in all of the dogs except in 1 in which
120 minutes of continuous infusion was required.
Rethrombosis did not occur in any of veins after TL.
The thrombectomized surfaces had the greatest
platelet deposition (Fig 2). No differences were
observed in fibrin deposition among the groups.
Organ chamber studies
The responses of the smooth muscles in any
given condition varied greatly within the thrombec-
tomized vessels. One entire vessel from a TX dog
and a ring from another TX dog were not responsive
and thus were excluded in data analysis.
L-NMMA caused no change in tensions from the
baseline to the maximal tension that was developed
to NE (10-4 mol/L). The presence or the absence of
the endothelium had no influence on the contrac-
tions to NE or PGF2a in any group. When compared
among the groups, the contractions to both NE
(10-4 mol/L) and PGF2 a (3 · 10-7 mol/L) were
lowest in the TX group (Table I). 
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Fig 2. Platelet (left) and fibrin (right) deposition in canine femoral veins after sham opera-
tion, thrombolysis, and thrombectomy. Data are shown as mean ± standard error of the mean
of platelet counts (platelet/cm2 and m g/cm2, for platelet and fibrin deposition, respectively).
*, Statistical significance by analysis of variance, thrombectomy versus all others (P < .05).
Serotonin
Serotonin caused concentration-dependent con-
tractions in all veins. The endothelium-dependent
decrease in contraction was observed only in the
veins from the NT group. This difference was oblit-
erated when the rings were incubated with L-
NMMA (Fig 3). When compared among the
groups, no significant differences in contractions
were observed in the rings with (Fig 4) or without
endothelium (data not shown; n = 5 to 8 per group).
Adenosine diphosphate
ADP caused concentration-dependent decreases in
tension evoked by PGF2a in rings both with and with-
out endothelium in all groups. Only in the rings from
the NT group were the relaxations to ADP signifi-
cantly attenuated in the rings with endothelium as
compared with the rings without endothelium (Fig 5).
In the rings with endothelium, the greatest relax-
ations were observed in the TL group, an effect that
was not altered at the removal of the endothelium
(Fig 6). L-NMMA did not alter the responses to
ADP in any of the treatment groups (data not
shown; n = 5 to 8 per group).
Calcium ionophore
In the rings with endothelium, the relaxations
to A23187 were significantly less after either TX or
TL as compared with the SH and NT groups (Fig
7). The relaxations to the ionophore were not
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Fig 3. Contractions to serotonin (5HT) in rings of canine femoral veins with and without
endothelium 48 hours after untreated experimental deep venous thrombosis in the absence of
(left) and presence of (right) NG-monomethyl-L-arginine. Data are expressed as percentage to
maximal contraction to norepinephrine (10-4 mol/L) and are shown as mean ± standard error
of the mean. *, Statistical significance by Student t test of area under curve (P < .05).
Table I. Contractions to norepinephrine (10-4 mol/L) and prostaglandin F2a (3 · 10-7 mol/L) in canine
femoral vein rings with and without endothelium
NE SH NT TL TX
With endothelium (n) 6.6 ± 1.0 (12) 3.8 ± 0.6 (10) 5.1 ± 1.1 (13) 2.3 ± 0.2 (10)*
Without endothelium (n) 5.4 ± 0.7 (12) 3.8 ± 0.5 (11) 5.2 ± 1.1 (12) 2.5 ± 0.4 (10)*
PGF2a SH NT TL TX
With endothelium (n) 3.6 ± 0.5 (12) 2.1 ± 0.3 (14) 2.3 ± 0.5 (15) 1.2 ± 0.1 (13)*
Without endothelium (n) 2.8 ± 0.4 (12) 2.3 ± 0.3 (12) 2.4 ± 0.5 (13) 1.2 ± 0.2 (10)*
SH, Sham operated; NT, no treatment; TL, thrombolysis; TX, thrombectomy; NE, norepinephrine; n, number of rings; PGF2 a ,
prostaglandin F2a .
*Statistical significance by analysis of variance, thrombectomy versus all other groups (P < .05).
Data are expressed as mean ± standard error of the mean.
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Fig 5. Relaxations to adenosine diphosphate (ADP) in rings of canine femoral veins with
untreated thrombus. Data are expressed as percent change in tension from contraction to
PGF2a and are expressed as mean ± standard error of the mean. *, Statistical significance by
Student t test of area under curve (P < .05).
Fig 4. Contractions to serotonin (5HT) in rings of canine femoral veins with endothelium 48
hours after experimental DVT that was not treated (NT), treated by thrombectomy (TX), or
thrombolysis (TL). Sham-operated veins (SH) are also shown. Data are expressed as percent-
age to maximal contraction to norepinephrine (10-4 mol/L) and are shown as mean ± stan-
dard error of the mean. No statistical significance was observed by analysis of variance of area
under curve.
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Fig 6. Relaxations to adenosine diphosphate (ADP) in canine femoral veins in the presence of
(left) and absence of (right) endothelium. Data are expressed as percent change in tension
from contraction to PGF2 a and are expressed as mean ± standard error of the mean.
Thrombolysis (TL) maintained greatest relaxations compared with all other groups in presence
of endothelium. When endothelium was removed, thrombolysis maintained greater relaxations
compared with thrombectomy (TX). *, Statistical significance by analysis of variance of area
under curve. P < .05 for thrombectomy versus urokinase in the presence of endothelium (left),
and thrombolysis versus all others in  in absence of endothelium (right). 
Fig 7. Relaxations to calcium ionophore A23187 in rings of canine femoral vein with
endothelium. Data are expressed as percent change in tension from contraction to PGF2a and
are shown as mean ± standard error of the mean. *, Significantly decreased relaxation in
thrombectomized and thrombolysed rings by analysis of variance of area under curve. P < .05
for thrombectomy versus sham and thrombolysis versus sham.
altered significantly by incubation with L-NMMA
(data not shown; n = 5 to 8 per group).
Nitric oxide
The relaxations to NO in the rings without
endothelium were significantly less only in those
rings from the thrombectomized segments (Fig 8).
The incubation of the rings with L-NMMA did not
affect the relaxations to NO (data not shown; n = 5
to 8 per group). 
Histologic study
Light microscopy revealed that TX caused signif-
icantly greater injury to the media of the veins (5 of
8 segments) as compared with SH (0 of 5), NT (0
of 7), and TL (1 of 6; c 2 test; P = .01; Fig 9). The
scoring of endothelial denudation of vein segments
that was prepared 3 hours after the treatment
showed minimal injury in the SH group, and signif-
icant endothelial denudation was found in both the
TX and the TL groups (Fig 10). The representative
SEMs from each category are shown in Fig 11. The
mechanical removal of the endothelium in the rings
that were studied in organ chamber was confirmed
by hematoxylin and eosin stain.
DISCUSSION
The present study reports for the first time a
direct comparison of physiologic effects of TL com-
pared with surgical TX in the treatment of experi-
mental DVT. TL preserved functional characteristics
of veins better than TX,—thrombogenicity was
reduced, and endothelial and smooth muscle func-
tions were preserved after TL.
As might be expected, differential effects on
valve competence were not observed between the 2
therapeutic methods in this short-term study. This is
consistent with the findings that incompetence did
not develop simultaneously with recanalization and
that in many cases reflux developed much later than
recanalization.27 It appears that the mechanics of
balloon TX do not render valves incompetent with-
in this time frame.
Platelet deposition was increased on the
thrombectomized surfaces. A lack of statistical signif-
icance in fibrin deposition is most likely related to the
rethrombosis of TX veins before the injection of
radioactive platelets and fibrin, which would not
allow the subsequent deposition of radioactive mate-
rials. Increased thrombogenicity is supported by the
findings of more frequent smooth muscle injury after
TX. At the exposure of the subendothelial matrix,
platelet adhesion to the vein wall occurs. This differ-
ential thrombogenicity may contribute to rethrom-
bosis and may delay time to complete recanalization,
which are important prognostic indicators for subse-
quent valvular dysfunction.1 The release from the
endothelium of antithrombotic substances also may
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Fig 8. Relaxations to nitric oxide in rings of canine femoral veins without endothelium. Data
are expressed as percent change in tension from contraction to prostaglandin F2a and are shown
as mean ± standard error of the mean. *, Significantly decreased relaxation in thrombectomized
and thrombolysed rings by analysis of variance of area under curve. P < .05 for thrombectomy
versus thrombolysis, versus sham, and thrombectomy versus no treatment.
differ between the two surfaces, thereby contributing
to the differences in thrombogenic potential.
The degree of anatomical injury to the endothe-
lial layer was comparable after TX and TL. However,
there also seems to be a loss in functional characteris-
tics after TX, as evidenced by the increase in throm-
bogenicity, the decrease in contractions to both NE
and PGF2a , and the decrease in relaxations to direct
NO stimulation. The contractions to serotonin, how-
ever, did not differ between the thrombectomized
and thrombolysed segments, which suggests selective
disruption of receptor-mediated processes. The
observed endothelium-dependent inhibition on con-
tractions to serotonin in the NT group may be
explained, at least in part, by the thrombus-induced
stimulation of NO synthase.
With respect to the functional analysis of the
endothelium-dependent responses, TL with uroki-
nase appears to preserve ADP-mediated relaxation
via both NO-dependent and NO-independent path-
ways (Fig 6). In fact, in the absence of endothelium,
the TL veins exhibited greater relaxations than the
SH vessels. This preservation of endothelial function
after TL is in agreement with our earlier findings in
arterial tree.24 The lack of difference in responses to
ADP between the rings with and without endotheli-
um can be explained by the fact that relaxation to
ADP is not entirely mediated by NO in this
model.28,29 One may speculate that nonendotheli-
um-dependent relaxing factors may play an impor-
tant role in ADP-mediated relaxations.
Relaxations to A23187, however, were decreased
comparably by both TX and TL. Because relaxations
to A23187 were not affected by L-NMMA, it is
unlikely that this represents a decrease in NO pro-
duction. Rather, an increase in the release of con-
tractile factors or a decrease in the relaxing factors,
other than NO,30-32 may account for the mechanism
by which urokinase affects the preservation of the
functional characteristics of the endothelium.
Arterial and venous thromboses in animal models
have documented increased inflammatory cytokine
and adhesion molecule expression.33-35 Yet, venous
thrombosis differs from that of the arterial system
clinically in that it involves a significant degree of
local inflammation and pain.34-36 This may be relat-
ed to thrombus-induced inflammatory responses that
are mediated by leukocyte adhesion to the venous
wall and the adjacent tissue, ultimately resulting in
rethrombosis, valvular destruction, and incompe-
tence. Recent data indicate that the inhibition of
cytokines and adhesion molecules can inhibit the
inflammatory response and rethrombosis.36-38
These inflammatory responses may be reduced
by urokinase. Urokinase has been shown to reduce
the serum level of circulating adhesion molecules in
acute coronary infarction39 and does not cause up-
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Fig 10. Endothelial injury assessment by means of scan-
ning electron microscopy on scale of 1 to 5: 1, 0 to 1% cell
loss; 2, 2% to 25% loss; 3, 26% to 50% loss; 4, 51% to 75%
loss; and 5, 76% to 100% loss. *, Statistical significance by
analysis of variance. P < .05 for thrombectomy versus
sham and thrombolysis versus sham.
Fig 9. Representative light microscopy of canine femoral
veins stained with methylene blue. A, After thrombolysis,
smooth muscle layer is intact. B, Deep injury to media of
vein is shown with thrombus on surface after thrombecto-
my. Magnification: · 40.
FPO
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Fig 11. Representative scanning electron micrographs of canine femoral veins. A, Grade 1.
Femoral vein freshly removed from normal dog. Endothelial layer is intact. B, Grade 2. Note
mild disruption of endothelial layer with leukocyte and platelet adhesion. C, Grade 3. Patchy
endothelial denudation with exposure of subendothelial matrix is evident. D, Grade 4.
Significant sloughing of endothelium with swelling is noted. E, Grade 5. Severe endothelial
denudation with underlying subendothelial matrix. Magnification: · 1000.
regulation of cell adhesion molecule expression or
alter leukocyte adhesion in an in vitro model.40
These characteristics of urokinase may also affect the
long-term outcome after DVT treatment.
Several therapeutic options are available for the
treatment of proximal DVT, including anticoagula-
tion therapy, TL, and TX. A collective review of the
randomized trials that compare TL using streptoki-
nase with heparin showed more effective clot lysis
and a lower incidence rate of postthrombotic syn-
drome with streptokinase (36% vs 80%).41-45 After
TX, widely varying clinical success rates and valvular
competence rates have been reported. The only
prospective randomized trial, which was reported by
Plate et al,14,18 that compared TX with temporary
arteriovenous fistula and anticoagulation therapy
against anticoagulation therapy alone failed to show
a lasting benefit of the surgical procedure at a 5-year
follow-up. In that series, 37% of the patients who
underwent TX were asymptomatic as compared with
18% in the medical group, with a valvular compe-
tence rate of 36% and 11%, respectively.18 Recently,
Juhan et al,20 in the longest follow-up of TX with
temporary arteriovenous fistula (mean, 8.5 years),
reported 84% patency rates and 56% valvular compe-
tence rates at 10 years.
Thus, it is unclear whether TL or TX will lend a
better outcome in the prevention of valvular incom-
petence and postthrombotic syndrome in humans.
The determining factors to a long-term outcome are
the rate and the degree of thrombus clearance and
the incidence rate of rethrombosis and recanaliza-
tion,1-3,20 which in turn are affected by the func-
tional statuses of the endothelium and SMCs.
To date, no prospective randomized trials have
been conducted that compare TL with TX in the
treatment of DVT in humans. The data from this
study suggest that early detection (within 48 hours)
and treatment of DVT is critical in maintaining the
functional integrity of the venous endothelium and
smooth muscle and that urokinase treatment of acute
DVT (less than 48 hours) reduces thrombogenicity
and preserves the endothelial and smooth muscle
functions. Because the study was performed in dogs
and was limited to DVT of 48 hours, no implication
should be made on DVT of older duration, and
extrapolation of experimental data to patients should
be done with caution. A demonstration of the long-
term effects of TL on venous morphology and func-
tion is also required. The study, however, provides
experimental evidence that justifies a need for a ran-
domized clinical trial of TL and TX for the manage-
ment of proximal DVT.
The authors would like to thank Mrs Marcia
Simonson for her editorial assistance and Mr William
Anding for his technical assistance.
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APPENDIX
The formula for fibrin deposition is derived on
the basis of the following:
Counting efficiency of Minaxi counter (Packard
Instrument, Downers Grove, Ill) for 125I: 54%
1 m Ci: 2.2 million disintegration/min.
Specific activity of fibrinogen: 80 Ci/mmol.
Molecular weight of fibrinogen: 380,000 g/mol.
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